NOV 24, 2017 4:52 PM PST

Gene Therapy Saves a Butterfly Child

WRITTEN BY: Carmen Leitch

Children that suffer from epidermolysis bullosa, sometimes called butterfly children because of their fragile skin, face incredible challenges. The devastating genetic disease impairs skin regeneration; even minor stresses on the skin can cause wounds, blisters and skin loss, resulting in scarring. If the patient’s internal organs are also affected, it can be life-threatening. Scientists have now reported the successful treatment of an affected child, using transplants made from genetically altered stem cells. It has been two years since the start of his treatment, and the boy can now participate more actively in family and social functions. The research team from Ruhr-Universität Bochum's burn unit and the Center for Regenerative Medicine at the University of Modena (Italy) have reported their work in Nature.

When this patient was first admitted to a pediatric intensive care unit in June 2015, 60 percent of his body was affected, and his life was in danger. Conventional treatments were failing. "He suffered from severe sepsis with high fever, and his body weight had dropped to a mere 17 kilograms - a life-threatening condition," Dr. Tobias Rothoeft, Consultant at the University Children's Hospital at Katholisches Klinikum Bochum. The disease would eventually affect 80 percent of the patient’s skin.

The terrible outlook for the boy prompted the team of pediatricians and plastic surgeons to go for an experimental approach. Stem cells were harvested from the patient through a skin biopsy. The researchers led by Professor Michele De Luca from the Center for Regenerative Medicine at the University of Modena altered epidermal stem cells with a retrovirus that can deliver a corrected version of the mutated gene that causes the child's disease. The modified stem cells that resulted from the procedure were made into transplants for the patient.  

They were applied to the arms, legs, back, flanks, the stomach, neck, and face of the boy. "Overall, 0.94 square meters of transgenic epidermis were transplanted onto the young patient in order to cover all defects, accounting for 80 percent of his entire body surface," said Associate Professor Dr. Tobias Hirsch, head consultant at the department of plastic surgery.

The first transplantation happened in October 2015, and the patient has been improving ever since. The genetically modified stem cells have formed new skin, and the binding proteins that are impaired in the disease are now intact in the transplanted areas. The retroviral gene transfer has been stable, successfully integrating the correct gene into the genome of the stem cells. The patient was discharged in February 2016. The patient has even been able to attend school, as stress-resistant skin has formed.

A baby with epidermolisis bullosa / Credit: Wikimedia Commons/Yovanna.Gonzalez

This is the first time a patient has been treated with transgenic epidermal stem cell transplants on a large area. "This approach has enormous potential for research into and development of new therapies for the treatment of epidermolysis bullosa as well as other diseases and trauma causing large skin defects," said Tobias Hirsch.

The massive scale of the transplant is thought to make the case unique worldwide. "Transplanting 80 percent of the skin and providing intensive medical care to the patient over a period of eight months was extremely challenging," Tobias Rothoeft and Tobias Hirsch noted. "The close collaboration between the departments in Bochum and the University of Modena's expertise [has] been the key to success. This makes us very proud."

While this treatment is not curative and cannot help patients whose internal organs are impacted, this is a major step in the right direction. The researchers are continuing their efforts, working now towards a treatment for another type of this kind of disease, dystrophic EB.

Sources: AAAS/Eurekalert! via Ruhr-Universität Bochum, Science, Nature

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 05, 2022
Cell & Molecular Biology
Making Genetic Engineering at the Chromosome Level Possible
SEP 05, 2022
Making Genetic Engineering at the Chromosome Level Possible
An image by Wang Qiang shows a mouse that carries two chromosomes fused together, the first engineered karyotype in mice ...
SEP 14, 2022
Genetics & Genomics
Neurodegeneration is Linked to Jumping Genes
SEP 14, 2022
Neurodegeneration is Linked to Jumping Genes
Scientists are beginning to reveal the secrets of the long, repetitive sequences in the human genome that were once writ ...
OCT 07, 2022
Genetics & Genomics
Epigenetic Marks Can Pass Down to Multiple Generations
OCT 07, 2022
Epigenetic Marks Can Pass Down to Multiple Generations
The earliest studies of genetic inheritance were very straightforward - Gregor Mendel documented the passage of certain ...
OCT 14, 2022
Drug Discovery & Development
Experimental Gene Therapy Restores Night Vision in Blind Patients
OCT 14, 2022
Experimental Gene Therapy Restores Night Vision in Blind Patients
Adults with a hereditary form of childhood-onset blindness experienced dramatic improvements in night vision within days ...
OCT 27, 2022
Genetics & Genomics
Creating a Gene Therapy to Treat an Iron Storage Disorder
OCT 27, 2022
Creating a Gene Therapy to Treat an Iron Storage Disorder
Hereditary hemochromatosis (HH) is caused by genetic mutations that lead to the abnormal accumulation of iron in differe ...
OCT 31, 2022
Genetics & Genomics
Ancient Viral DNA in Our Genome Has a Protective Function
OCT 31, 2022
Ancient Viral DNA in Our Genome Has a Protective Function
There is viral DNA in the human genome, and each instance traces back to an ancestor who was infected with a retrovirus. ...
Loading Comments...